Y-Intercept (HK)
LMAT icon

Y-Intercept (HK)’s LeMaitre Vascular LMAT Stock Holding History

Y-Intercept (HK)’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-20,871
Closed -$2M – 1871
2026
Q2 		$2M Buy
+20,871
New +$2.14M 0.04% 701
2026
Q1 		– Sell
-27,694
Closed -$2.25M – 1847
2025
Q4 		$2.25M Buy
27,694
+17,942
+184% +$1.54M 0.05% 578
2025
Q3 		$853K Buy
+9,752
New +$871K 0.02% 1049
2024
Q2 		– Sell
-3,059
Closed -$203K – 1679
2024
Q1 		$203K Buy
+3,059
New +$189K 0.02% 1152

Other funds holding LMAT

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
Linden Thomas Advisory Services
Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return
Chatham Capital Group
Chatham Capital Group Savannah, Georgia $777M AUM 22.3% 1-Year Est. Return
Annex Advisory Services
Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return
Illumine Investment Management
Illumine Investment Management Poulsbo, Washington $144M AUM 33.61% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Y-Intercept (HK)'s LMAT Position: Q3 2026 in Review

Y-Intercept (HK) sold out of LeMaitre Vascular (LMAT) in Q3 2026, closing a stake of 20,871 shares — an estimated $2M sold.

Y-Intercept (HK) first reported a position in LMAT in Q1 2024 and held it in 4 quarters. The position peaked at $2.25M in Q4 2025. 39 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Y-Intercept (HK) reported no remaining LeMaitre Vascular position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 20,871 LeMaitre Vascular shares in Q3 2026, an estimated $2M.
  • Y-Intercept (HK) first reported a position in LeMaitre Vascular in Q1 2024 and held it in 4 quarters.
  • Y-Intercept (HK)'s LeMaitre Vascular position peaked at $2.25M in Q4 2025.
  • 39 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.